Clinical Validation of the Lexie Lumen Hearing Aid
NCT05337748 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68
Last updated 2025-03-20
Summary
More than half a billion people globally have hearing loss. Most hearing loss is sensorineural, meaning that the hearing loss is irreversible and requires rehabilitation. The majority of people with hearing loss have mild to moderate degrees, for which the most effective treatment options are hearing aids. Over the past few years, there have been many developments in hearing technology and the service delivery models in which they are supplied. Traditional hearing care models include several visits to a qualified hearing professional who must both perform diagnostics and prescribe hearing aids, which in the past has been the only way to obtain hearing aids. However, newer developments include forms of self-fitting hearing aids that enable a user to perform threshold measurements to determine the degree of hearing loss and automatically program and fine-tune hearing aids. These devices are now becoming available as direct-to-consumer (DTC) or over-the-counter (OTC) hearing aids. Furthermore, alternative care models have been suggested to bolster access and uptake of assistive technology for hearing loss. Regulations on DTC and OTC hearing aids are starting to come into effect. In 2017, the FDA Reauthorization Act of 2016 directed the FDA to create a category for OTC hearing aids for adults with perceived mild-to-moderate hearing loss. In October 2021, the FDA formally proposed a rule to establish the OTC hearing aid category as part of this process. These changes in regulations would mean that soon, many of these self-fitting devices will become available. In response to these changes in service delivery models, the hearX group recently developed the Lexie Lumen hearing aids that can perform in-situ hearing threshold estimations and automatically prescribe hearing aid gain settings that closely approximate the gold-standard NAL-NL2 fitting prescription. This study aims to evaluate whether the performance of the novel Lexie self-test and self-fitting hearing aid is equivalent to the same hearing aid programmed professionally by an audiologist using a professionally obtained audiogram.
Conditions
Interventions
- DEVICE
-
Lexie Self Test and Fit Group
The intervention offered is a hearing aid fitting with Lexie Lumen hearing aids coupled with a slimtube and dome. The hearing aids will be accompanied and operated using the Lexie smartphone application. Participants will self-perform an in-situ hearing check (pure tones presented via the hearing aids). The prescriptive gain of the hearing aids will be programmed and applied automatically using the obtained in-situ hearing thresholds. Participants will be fitted according to the customized, Lexie optimal fit prescribed gain setting. The optimal settings include the original gain and compression requirements that NAL-NL2 suggests for various audiograms. No additional band equalizer or compression adjustments are added. After a specified period of time, participants will be able to self-adjust the hearing aids using the smartphone application.
- DEVICE
-
Lexie Professional Test and Fit Group
The intervention offered is a hearing aid fitting with Lexie Lumen hearing aids coupled with slimtube and dome. Hearing aids will be fitted by a certified audiologist according to a gold-standard prescriptive formula (NAL-NL2) using a clinically obtained diagnostic pure tone audiogram. Participants will have access to the smartphone application, but the settings will be limited with only options to change the volume of the hearing aids.
Sponsors & Collaborators
-
University of Pretoria
collaborator OTHER -
hearX Group
lead INDUSTRY
Principal Investigators
-
De Wet Swanepoel, PhD · hearX Group
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-04-11
- Primary Completion
- 2022-10-01
- Completion
- 2022-10-01
- FDA Device
- Yes
Countries
- South Africa
Study Locations
More Related Trials
-
Speech Intelligibility in Quiet and Noise for New vs. Legacy Hearing Aids
NCT05101083 ·Status: COMPLETED ·Phase: NA
-
Self Fitting Hearing Aid Clinical Investigation
NCT05612763 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Rehabilitation Results in the Single-sided Deafness With Cochlear Implantation
NCT05435612 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Outcomes of Hearing Aids
NCT04030299 ·Status: COMPLETED ·Phase: NA
-
Benefits of Assistive Listening Device for Speech Intelligibility
NCT05072470 ·Status: COMPLETED ·Phase: NA
-
Evaluating a Deep Neural Noise-Reduction Algorithm for Hearing Aids
NCT07287774 ·Status: RECRUITING ·Phase: NA
-
Pitch and Loudness Perception by Cochlear Implant Listeners: Psychophysics and Objective Measures
NCT01284790 ·Status: TERMINATED ·Phase: NA
-
Evaluation of In-lab Benefit for Speech-in-noise Intelligibility With Device for Adults With Mild to Moderate Hearing Loss
NCT07074769 ·Status: COMPLETED ·Phase: NA
-
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
NCT05312983 ·Status: RECRUITING ·Phase: NA
-
Optimizing Bilateral and Single-sided-deafness Cochlear Implants for Functioning in Complex Auditory Environments
NCT06305039 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Clinical Metrics for Assessing Cochlear Implant Recipient MAPs
NCT02746172 ·Status: COMPLETED ·Phase: NA
-
Hearing Aids Use in Elderly: Efficacy in Speech Perception and in Health-related Quality of Life
NCT04333043 ·Status: COMPLETED
-
Hearing Aids and the Brain
NCT03279510 ·Status: COMPLETED ·Phase: NA
-
Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation
NCT06301568 ·Status: COMPLETED
-
Preoperative Variables Affecting Outcome Of Cochlear Implant
NCT03719963 ·Status: UNKNOWN
-
Cochlear Implantation for Young Single-sided Deaf Children
NCT04738968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Retrospective CI532 Hearing Performance
NCT03039283 ·Status: COMPLETED
-
A Self-Affirmation Intervention to Promote Hearing Aid Use
NCT04382703 ·Status: UNKNOWN ·Phase: NA
-
Barriers and Facilitators to OTC Hearing Aids Success
NCT06499805 ·Status: RECRUITING ·Phase: NA
-
The Influence of the Individual Auditory-cognitive Need on the Aided Benefit Using Different Feature Settings
NCT06420037 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Revised Indication for Determining Adult Cochlear Implant Candidacy
NCT01337076 ·Status: COMPLETED ·Phase: NA
-
Cognitive Function and EEG Brain Network Remodeling Among Users of Hearing Aids With ARHL
NCT06893432 ·Status: ACTIVE_NOT_RECRUITING
-
Lyric Self-replacement Clinical Investigation
NCT05349981 ·Status: COMPLETED ·Phase: NA
-
Speech Locator_Benefits in Pediatric Popluations
NCT06533774 ·Status: TERMINATED ·Phase: NA
-
Quality Control of CE-Certified Phonak Hearing Aids - 2017_37
NCT03379766 ·Status: COMPLETED ·Phase: NA